What are the possible diagnoses for a patient presenting with new‑onset dyspnea, a dry cough that worsens when supine, generalized myalgias (especially back), headache, subjective fever with profuse sweating, and intermittent nasal congestion?

Differential Diagnosis: Acute Respiratory Illness with Systemic Symptoms

The most likely diagnosis in this patient is a viral respiratory infection, most commonly influenza or COVID-19, given the constellation of fever, dry cough worsening when supine, generalized myalgias (especially back pain), headache, profuse sweating, and mild nasal congestion. 1, 2, 3

Primary Diagnostic Considerations

Viral Respiratory Infections (Most Likely)

Influenza should be the leading consideration when cough and fever appear simultaneously within 48 hours of symptom onset, particularly when accompanied by the characteristic triad of weakness, myalgias, and cough occurring in >90% of cases 3. The profuse sweating and severe body aches, especially affecting the back, are highly characteristic of influenza 3.

COVID-19 remains a critical differential diagnosis, typically presenting with fever, dry cough, and fatigue, often accompanied by nasal congestion 1, 3. The clinical symptoms described—fever, dry cough, dyspnea, myalgia, and headache—match the most prevalent COVID-19 manifestations reported in large case series (fever 92.8%, cough 69.8%, dyspnea 34.5%, myalgia 27.7%, headache 7.2%) 1. The subjective fever with profuse sweating is consistent with COVID-19 presentation 4.

Post-infectious cough from a recent viral upper respiratory infection is suggested when productive cough, fever around 38-39°C, and systemic symptoms resolve within 5 days with only symptomatic therapy, though this patient's non-productive cough and ongoing symptoms make an active infection more likely 2.

Positional Cough: Key Diagnostic Feature

The cough worsening when lying down is a critical diagnostic clue that narrows the differential 1. This positional component suggests:

• Post-nasal drip/Upper Airway Cough Syndrome (UACS) from viral rhinosinusitis, which commonly causes cough that worsens supine due to posterior pharyngeal drainage 2, 5
• Gastroesophageal reflux disease (GERD), though less likely given the acute presentation with fever and systemic symptoms 1, 2
• Heart failure must be considered when dyspnea and cough worsen when supine, though the acute febrile presentation with myalgias makes this less likely 1

Less Common but Important Differentials

Acute bacterial sinusitis should be considered only if symptoms persist >10 days without improvement AND the patient has purulent nasal discharge AND facial pain/pressure—all three criteria must be met 2. The current presentation with mild intermittent nasal congestion does not meet these criteria.

Pneumonia (viral or bacterial) must be excluded, particularly given the dyspnea 1. Bilateral diffuse infiltrates on imaging would support viral pneumonia, while lobar consolidation suggests bacterial etiology 1.

Acute lupus pneumonitis presents with rapid onset of fever, cough, and dyspnea, but typically occurs in patients with known or newly diagnosed SLE, often with additional features like arthritis, serositis, rash, cytopenias, or renal dysfunction 6. This is unlikely without these additional systemic features.

Diagnostic Approach Algorithm

Immediate Assessment (Day 1)

1. Characterize the timeline: Viral URI is suggested when symptoms resolve within 5 days with symptomatic therapy alone 2

2. Assess for red-flag symptoms requiring urgent evaluation 3:

   • Respiratory distress or severe dyspnea
   • Persistent fever >5 days
   • Signs of dehydration
   • Altered consciousness or neck stiffness
   • Hemoptysis

3. Targeted testing based on epidemiological context 3:

   • COVID-19 testing (PCR or rapid antigen) given the pandemic context and compatible symptoms 1, 3
   • Rapid influenza testing if presenting during flu season and within 48 hours of symptom onset (to guide antiviral therapy) 3
   • Chest radiography if dyspnea is prominent or clinical examination suggests pneumonia 1

4. Physical examination priorities 1:

   • Auscultate for inspiratory crackles (suggests interstitial lung disease or pneumonia)
   • Assess respiratory rate and oxygen saturation
   • Examine for signs of consolidation

Initial Management (Days 1-5)

For presumed viral respiratory infection 2:

• Inhaled ipratropium bromide (2-3 puffs 4× daily) has the strongest evidence for reducing mucus hypersecretion and airway inflammation 2
• Supportive care: Adequate hydration, warm facial packs, steamy showers, head-of-bed elevation (particularly important given positional cough) 2
• Guaifenesin 200-400 mg every 4 hours (up to 6 times daily) to loosen phlegm 2
• Honey with lemon for symptomatic relief 2

Critical pitfall to avoid: Do NOT prescribe antibiotics for post-infectious cough—they provide no benefit and should never be prescribed for this indication 2. Do NOT assume that colored sputum indicates bacterial infection; it is common in viral illnesses 2.

Reassessment (Days 5-10)

If symptoms persist or worsen after 5 days:

1. Add first-generation antihistamine-decongestant combination (e.g., brompheniramine/pseudoephedrine) for presumed upper airway cough syndrome, with clinical improvement typically seen within days to 1-2 weeks 2. Note: Newer non-sedating antihistamines like loratadine are ineffective for this condition 2.

2. Consider intranasal corticosteroid spray (fluticasone or mometasone) for persistent upper-airway inflammation 2, 5

3. Re-evaluate for bacterial superinfection if fever reappears or persists beyond 3-5 days, or if clinical worsening occurs after initial improvement 2

Extended Evaluation (Days 10-21)

If cough persists beyond 10 days without improvement:

1. Assess for bacterial sinusitis only if ALL three criteria are met: symptoms >10 days without improvement, purulent nasal discharge, AND facial pain/pressure 2

2. Consider inhaled corticosteroids (fluticasone 220 µg or budesonide 360 µg twice daily) if cough markedly impairs quality of life, allowing up to 8 weeks for full response 2

3. Reserve oral prednisone (30-40 mg daily for 5-10 days) for severe cough paroxysms significantly affecting quality of life, after excluding UACS, asthma, and GERD 2

Chronic Cough Evaluation (>8 weeks)

If cough persists >8 weeks, reclassify as chronic cough and systematically evaluate for 2:

• Upper-airway cough syndrome (UACS)
• Asthma or cough-variant asthma
• Gastroesophageal reflux disease (GERD)
• Obtain chest radiograph and consider spirometry at this point

Common Pitfalls to Avoid

• Do NOT obtain sinus imaging within the first week of symptoms because radiographic abnormalities are present in ≈87% of common colds and resolve spontaneously without antibiotics in ≈79% of cases 2

• Do NOT overlook underlying asthma: If cough persists despite treatment for UACS, a bronchodilator trial and spirometry should be considered 2

• Do NOT continue antitussive therapy beyond 3 weeks without reassessment 2

• Do NOT assume interstitial lung disease causes chronic cough without first completely evaluating for more common causes (asthma, UACS, GERD), as >50% of ILD patients referred to cough clinics have cough from these other conditions 7